Well-being/Quality of LifeNCT07400081
Effectiveness of a Community-based Intervention Programme to Promote Well-being in Older Adults
A study testing Community-based Intervention in people with Well-being/Quality of Life and Mental Health, run by National Healthcare Group Polyclinics at 1 site in Singapore.
Trial summary
This study is conducted to assess the effectiveness of a community intervention programme on improving well-being, levels of distress, and loneliness in older adults (aged 55 years old and above), who have symptoms of depression. Social Service Agencies (SSAs) will conduct focal talks on well-being for the community. Read more about this study
- Who is it for?
- Ages 55 years and olderHealthy volunteers can take part
- Conditions the study is for
- Well-being/Quality of Life, Mental Health
- What is being tested?
- Community-based Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 300 participants
- Where
- 1 siteSingapore
- Study dates
- Mar 2026to Dec 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Aged 55 and above
- Score of 1-9 on the PHQ-9 questionnaire
- Able to speak and understand English, Chinese or Malay
- Able to provide informed consent
- Be willing to use common technologies (such as phone calls, texting via SMS/whatsapp) for communication
Who cannot join
- PHQ-9 score of 0
- PHQ-9 score of 10 or more
- Actively being followed up by a mental health professional
- On psychotropic medication or are undergoing psychotherapy
- Have other mental disorders or are suicidal
- Have physical difficulties, cognitive impairment or difficulties with speech, sight and hearing or mobility that may prevent their engagement in activities
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Singapore1 site
National Healthcare Group Polyclinics
Singapore, Singapore, 308205
Eugene YC Chua, +6563553000, eugene.yc.chua@nhghealth.com.sg
About this study
This study is conducted to assess the effectiveness of a community intervention programme on improving well-being, levels of distress, and loneliness in older adults (aged 55 years old and above), who have symptoms of depression.
Social Service Agencies (SSAs) will conduct focal talks on well-being for the community. As part of the focal talks, the Public Health Questionnaire-9 (PHQ-9) will be conducted. Attendees with a PHQ-9 score of 1-9 will be invited to take part in the study. Up to 300 participants will be recruited and randomised into 2 arms: control arm (150 participants) and intervention arm (150 participants).
Participants in the intervention arm will undergo 8-week community intervention programme which includes 4 sessions on well-being and continuous follow-up with a Health Companion. Participants in the control arm will be offered to join a programme conducted by the SSAs 8 weeks after recruitment into the study. The programmes offered to the control group are independent of the study.
Read the detailed description
Study Procedures:
Control arm: Participants randomised into the control arm will not be offered any programmes for 8 weeks after their recruitment into the study. After 8 weeks, the SSAs will offer the participants an intervention programme that is independent of the study.
Intervention arm: Participant in the intervention arm will undergo 4 face-to-face, group psychoeducation sessions, conducted fortnightly over a period of 8 weeks. The sessions will teach the participants about well-being and share with them strategies to improve their well-being. Health Companions from the SSAs will conduct check-ins with the participants over the phone, and recommend some nearby activities for them.
Methods and assessments:
Questionnaires including the 6-item De Jong Gierveld Loneliness Scale, Warwick-Edinburgh Mental Wellbeing Scale, Patient Health Questionnaire-9, and Generalised Anxiety Disorder-7 at the baseline and endpoint for all participants.
Expected risks:
During the administration of the questionnaires, participants may feel uncomfortable or upset. Participants may choose to refuse to asnwer any of the questions, or take a break at any time during the questionnaire administration.
Participants in the intervention arm may feel discomfort, anxiousness or distress while undergoing the intervention programme. Participants may cease their enrolment in the study, or be encouraged to attend clinical follow-ups or reach out to the Social Service Agencies' Community Intervention Team (COMIT).
Safety Review Plan:
As this study does not involve any invasive procedures, the study team does not foresee any adverse events related to the study.
Data Quality Assurance:
The PI or study team member will review all data collection forms on an ongoing basis for data completeness, accuracy and protocol compliance, after every data collection timepoint.
Data entry and storage:
For hardcopy data, they will be stored in designated locked cabinet(s) or room(s) that are accessible to authorized study personnel only. For electronic data, they will be stored on in a secured computer that is password protected. The databases will not contain subject identifiers and the data linking subject identifiers and the subject identification codes will be stored separately.
Sample size calculation:
An a priori power analysis was conducted to determine the required sample size for detecting a statistically significant difference in the primary outcome, the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), between the intervention and control arms. The effect size based on standardised mean differences (SMD) for this calculation was informed by a comprehensive systematic review by Blodgett et al. (2022), which reported a medium to large range of SMD from 0.38 to 0.72 for selected themes and subthemes of intervention across studies. To ensure the study is adequately powered for a conservative estimate, the smallest effect size from this range, d = 0.38, was used for the calculation. The power analysis was performed for a two-tailed independent samples t-test using the pwr package in R, with a standard significance level (α) of 0.05 and a desired power (1-β) of 0.80. The results indicated that a minimum of 110 participants per group is required. To account for a potential 20% attrition rate, the minimum recruitment target is about 130 participants per arm. The study team rounded up the number to 150 participants per arm, with a total of 300 participants to be recruited.
Statistical and analytical plans:
Data will be analysed using SPSS/Stata/R. Normality of the data will be checked using the Kolmogorov-Smirnov test. Differences between variables will be tested by t-test and Mann-Whitney U test for normal and non-normal continuous variables respectively and chi-square test or Fisher-exact test for categorical variables. Associations with the improvement in scores will be analysed via multivariable regressions. P value <0.05 will indicate statistical significance.
- Conditions
- Well-being/Quality of Life, Mental Health
- Being tested
- Community-based Intervention
- Keywords
- Community-based intervention, Well-being, Older adults, Mental Health
- Medical subject headings
- Psychological Well-Being
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Community-based InterventionBehavioural
Psychoeducation Programme
| Study group | Role | What they receive |
|---|---|---|
| Control | No intervention | Waitlist Control |
| Intervention | Other | Community-based Intervention Receives: Behavioral: Community-based Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Well-being
Measured by Warwick-Edinburgh Mental Well-being Scale (WEMWBS) Minimum score: 7 Maximum score: 35 Higher scores indicate higher positive mental well-being (Better outcome).
Measured: 8 weeks
Secondary outcomes (3)
Depressive symptoms
Measured by Patient Health Questionnaire-9 (PHQ-9) Minimum score: 0 Maximum score: 27
Higher scores represent higher severity of the symptoms of depression (worse outcome).
Specifically, scores of 0-4 represent none to minimal depression severity; scores of 5-9 represent mild depression severity; scores of 10-14 represent moderate depression; scores of 15-19 represent moderately severe depression; scores of 20-27 represent severe depression.
Measured: 8 weeks
Anxiety symptoms
Measured by Generalised Anxiety Disorder-7 (GAD-7) Minimum score: 0 Maximum score: 21
Higher scores represent higher severity of anxiety symptoms (worse outcome). Specifically, scores of 0-4 represent minimal anxiety; scores of 5-9 represent mild anxiety; scores of 10-14 represent moderate anxiety; scores of 15-21 represent severe anxiety.
Measured: 8 weeks
Loneliness
Measured by De Jong Gierveld Loneliness Scale Minimum score: 0 Maximum score: 6 Higher scores represent higher severity of loneliness (worse outcome). Specifically, scores of 0-2 represent low levels of loneliness; scores of 3-4 represent moderate levels of loneliness; scores of 5-6 represent intense/severe levels of loneliness.
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Feb 2026
- Study startMar 2026 (estimated)
- Primary completionDec 2027 (estimated)
- Study completionDec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Well-being/Quality of LifeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Community-based intervention through structured psychoeducation and social prescription
- Masking
- None (open label)
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Healthcare Group Polyclinics
- Sponsor type
- Other government
- Collaborators
- Lien Foundation, Institute of Mental Health, Singapore, Nanyang Technological University, Fei Yue Community Services, Club HEAL
- Responsible party
- Principal investigator, Chua Yu Cong, Eugene, National Healthcare Group Polyclinics
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07400081
- Sponsor's protocol ID
- 2025-1289
- Status last verified
- Jan 2026
- First submitted
- 3 Feb 2026
- Last updated
- 13 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of a Community-based Intervention Programme to Promote Well-being in Older Adults
- ClinicalTrials.gov ID
- NCT07400081
- Acronym / sponsor ID
- 2025-1289
- Conditions
- Well-being/Quality of Life, Mental Health
- Keywords
- Community-based intervention, Well-being, Older adults, Mental Health
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- National Healthcare Group PolyclinicsOther government
- Collaborators
- Lien Foundation, Institute of Mental Health, Singapore, Nanyang Technological University, Fei Yue Community Services, Club HEAL
- Study start
- Mar 2026 (estimated)
- Primary completion
- Dec 2027 (estimated)
- Study completion
- Dec 2028 (estimated)
- First posted
- 10 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is conducted to assess the effectiveness of a community intervention programme on improving well-being, levels of distress, and loneliness in older adults (aged 55 years old and above), who have symptoms of depression.
Social Service Agencies (SSAs) will conduct focal talks on well-being for the community. As part of the focal talks, the Public Health Questionnaire-9 (PHQ-9) will be conducted. Attendees with a PHQ-9 score of 1-9 will be invited to take part in the study. Up to 300 participants will be recruited and randomised into 2 arms: control arm (150 participants) and intervention arm (150 participants).
Participants in the intervention arm will undergo 8-week community intervention programme which includes 4 sessions on well-being and continuous follow-up with a Health Companion. Participants in the control arm will be offered to join a programme conducted by the SSAs 8 weeks after recruitment into the study. The programmes offered to the control group are independent of the study.
Detailed description
Study Procedures:
Control arm: Participants randomised into the control arm will not be offered any programmes for 8 weeks after their recruitment into the study. After 8 weeks, the SSAs will offer the participants an intervention programme that is independent of the study.
Intervention arm: Participant in the intervention arm will undergo 4 face-to-face, group psychoeducation sessions, conducted fortnightly over a period of 8 weeks. The sessions will teach the participants about well-being and share with them strategies to improve their well-being. Health Companions from the SSAs will conduct check-ins with the participants over the phone, and recommend some nearby activities for them.
Methods and assessments:
Questionnaires including the 6-item De Jong Gierveld Loneliness Scale, Warwick-Edinburgh Mental Wellbeing Scale, Patient Health Questionnaire-9, and Generalised Anxiety Disorder-7 at the baseline and endpoint for all participants.
Expected risks:
During the administration of the questionnaires, participants may feel uncomfortable or upset. Participants may choose to refuse to asnwer any of the questions, or take a break at any time during the questionnaire administration.
Participants in the intervention arm may feel discomfort, anxiousness or distress while undergoing the intervention programme. Participants may cease their enrolment in the study, or be encouraged to attend clinical follow-ups or reach out to the Social Service Agencies' Community Intervention Team (COMIT).
Safety Review Plan:
As this study does not involve any invasive procedures, the study team does not foresee any adverse events related to the study.
Data Quality Assurance:
The PI or study team member will review all data collection forms on an ongoing basis for data completeness, accuracy and protocol compliance, after every data collection timepoint.
Data entry and storage:
For hardcopy data, they will be stored in designated locked cabinet(s) or room(s) that are accessible to authorized study personnel only. For electronic data, they will be stored on in a secured computer that is password protected. The databases will not contain subject identifiers and the data linking subject identifiers and the subject identification codes will be stored separately.
Sample size calculation:
An a priori power analysis was conducted to determine the required sample size for detecting a statistically significant difference in the primary outcome, the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), between the intervention and control arms. The effect size based on standardised mean differences (SMD) for this calculation was informed by a comprehensive systematic review by Blodgett et al. (2022), which reported a medium to large range of SMD from 0.38 to 0.72 for selected themes and subthemes of intervention across studies. To ensure the study is adequately powered for a conservative estimate, the smallest effect size from this range, d = 0.38, was used for the calculation. The power analysis was performed for a two-tailed independent samples t-test using the pwr package in R, with a standard significance level (α) of 0.05 and a desired power (1-β) of 0.80. The results indicated that a minimum of 110 participants per group is required. To account for a potential 20% attrition rate, the minimum recruitment target is about 130 participants per arm. The study team rounded up the number to 150 participants per arm, with a total of 300 participants to be recruited.
Statistical and analytical plans:
Data will be analysed using SPSS/Stata/R. Normality of the data will be checked using the Kolmogorov-Smirnov test. Differences between variables will be tested by t-test and Mann-Whitney U test for normal and non-normal continuous variables respectively and chi-square test or Fisher-exact test for categorical variables. Associations with the improvement in scores will be analysed via multivariable regressions. P value <0.05 will indicate statistical significance.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Community-based intervention through structured psychoeducation and social prescription
| Arm | Type | Receives |
|---|---|---|
| Control | No intervention | –Waitlist Control |
| Intervention | Other | Behavioral: Community-based InterventionCommunity-based Intervention |
Who may qualify
- Ages
- 55 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Aged 55 and above
- Score of 1-9 on the PHQ-9 questionnaire
- Able to speak and understand English, Chinese or Malay
- Able to provide informed consent
- Be willing to use common technologies (such as phone calls, texting via SMS/whatsapp) for communication
Key exclusion criteria (6 listed)
- PHQ-9 score of 0
- PHQ-9 score of 10 or more
- Actively being followed up by a mental health professional
- On psychotropic medication or are undergoing psychotherapy
- Have other mental disorders or are suicidal
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Community-based InterventionPsychoeducation Programme | Behavioural | Intervention |
Primary outcome
Well-being
Time frame: 8 weeks
Measured by Warwick-Edinburgh Mental Well-being Scale (WEMWBS) Minimum score: 7 Maximum score: 35 Higher scores indicate higher positive mental well-being (Better outcome).
3 secondary outcomes
Depressive symptoms
Time frame: 8 weeks
Anxiety symptoms
Time frame: 8 weeks
Loneliness
Time frame: 8 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Well-being/Quality of Life
Active, not recruitingPhase 2
Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers
Metastatic Malignant Female Reproductive System Neoplasm
Not yet recruiting
Psychotherapy in Patients With Endometriosis: Cognitive Behavioral Therapy Versus Acceptance and Commitment Therapy
Endometriosis, Adenomyosis
Active, not recruiting
Supporting Health in Veterans With Heart Failure
Heart Failure
Not yet recruiting
"CORE Training for Musculoskeletal Health: A Study on Adaptive Exercise Protocols"
Core Muscle Weakness, Postural Control Deficit
Active, not recruiting
PREWELL Digital Well-being Promotion Intervention With the BitHabit App
General Mental Health and Well-Being, Mental Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Community-based Intervention in people with Well-being/Quality of Life and Mental Health, run by National Healthcare Group Polyclinics at 1 site in Singapore.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Eugene YC Chua (+6563553000, eugene.yc.chua@nhghealth.com.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Well-being (time frame: 8 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.